SEC EDGAR: material events, stakes, listings, share offerings, annual and quarterly reports.
Showing Monday 14 September 2026. Back to the latest
Monday 14 September 2026
878 records- 8-K
Cambium Networks Corp reports bankruptcy or receivership
Form 8-K, items 1.03, 2.05, 5.02. Also reports exit or restructuring costs; reports a director or officer change.
- 8-K
Texas Capital Bancshares Inc/Tx received a delisting or listing-standard notice
Form 8-K, items 3.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
SmartKem, Inc. received a delisting or listing-standard notice
Form 8-K, item 3.01.
- Delisting
Nasdaq Stock Market LLC filed to remove Comcast Corp from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
New York Stock Exchange LLC filed to remove Shell plc from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
New York Stock Exchange LLC filed to remove Banco Santander, S.A. from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
New York Stock Exchange LLC filed to remove Shell International Finance B.V. from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
New York Stock Exchange LLC filed to remove Barclays PLC from listing
Form 25-NSE, notice of removal from listing and registration.
- Delisting
New York Stock Exchange LLC filed to remove Teva Pharmaceutical Industries Ltd from listing
Form 25-NSE, notice of removal from listing and registration.
- 8-K
Sionna Therapeutics, Inc. reports exit or restructuring costs
Form 8-K, items 2.05, 5.02, 8.01. Also reports a director or officer change; reported other events.
- Stake 13D
New stake of 5% or more by a holder who may seek influence
Schedule 13D naming Bokhari Raza and Medicus Pharma Ltd.
- 8-K
Z Squared Inc. completed an acquisition or disposal
Form 8-K, items 1.01, 2.01, 3.02. Also entered a material agreement; sold shares without registration.
- 8-K
Veracyte, Inc. completed an acquisition or disposal
Form 8-K, items 1.01, 2.01, 7.01. Also entered a material agreement; made a Regulation FD disclosure.
- 8-K
Quince Therapeutics, Inc. completed an acquisition or disposal
Form 8-K, items 2.01, 5.02. Also reports a director or officer change.
- 8-K
Ondas Inc. completed an acquisition or disposal
Form 8-K, items 1.01, 2.01, 3.02, 7.01, 8.01. Also entered a material agreement; sold shares without registration; made a Regulation FD disclosure; reported other events.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming JBDI Holdings Ltd and Siow Kim Lian.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Atlas Capital Resources (A9) LP and Vulcan Infrastructure & Power Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Anghami Inc and OSN Streaming Ltd.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming TDR Capital II Investments LP and Target Hospitality Corp.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Hagerty, Inc. and Markel Group Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Anghami Inc and Warner Bros. Discovery, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Foglia Stephanie Athena and Mistras Group, Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Sezzle Inc. and Youakim Charles.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Apeiron Investment Group Ltd. and AtaiBeckley Inc.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming M&G Investment Management Ltd and Methanex Corp.
- Stake 13D
Updated stake of 5% or more by a holder who may seek influence
Schedule 13D/A naming Aberdeen Government Markets Income Fund and Sit Investment Associates Inc.
- 8-K
Thryv Holdings, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Upexi, Inc. entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Odyssey Marine Exploration Inc entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Yarrow Bioscience, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Rainmaker Worldwide Inc. ended a material agreement
Form 8-K, items 1.02, 5.02. Also reports a director or officer change.
- 8-K
Plains GP Holdings LP entered a material agreement
Form 8-K, items 1.01, 2.02, 2.03, 8.01. Also took on a new financial obligation; published results; reported other events.
- 8-K
XCF Global, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
byNordic Acquisition Corp entered a material agreement
Form 8-K, items 1.01, 2.03, 8.01. Also took on a new financial obligation; reported other events.
- 8-K
Rainmaker Worldwide Inc. ended a material agreement
Form 8-K, items 1.02, 5.02. Also reports a director or officer change.
- 8-K
XBP Global Holdings, Inc. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
VisionWave Holdings, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
PDS Biotechnology Corp ended a material agreement
Form 8-K, items 1.02, 5.02. Also reports a director or officer change.
- 8-K
Nomadar Corp. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Trilogy Metals Inc. entered a material agreement
Form 8-K, items 1.01, 3.02, 7.01, 8.01. Also sold shares without registration; made a Regulation FD disclosure; reported other events.
- 8-K
Plains All American Pipeline LP entered a material agreement
Form 8-K, items 1.01, 2.03, 8.01. Also took on a new financial obligation; reported other events.
- 8-K
Treasure Global Inc entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Onconetix, Inc. entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Perdoceo Education Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
Toyota Motor Credit Corp entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Elmet Group Co. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Hain Celestial Group Inc entered a material agreement
Form 8-K, item 1.01.
- 8-K
Embrace Change Acquisition Corp. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Glucotrack, Inc. entered a material agreement
Form 8-K, items 1.01, 5.07. Also reported shareholder vote results.
- 8-K
Harvard Apparatus Regenerative Technology, Inc. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Hyperliquid Strategies Inc entered a material agreement
Form 8-K, item 1.01.
- 8-K
Medicus Pharma Ltd. ended a material agreement
Form 8-K, item 1.02.
- 8-K
American Tower Corp /MA/ entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Addus HomeCare Corp entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Bally's Corp entered a material agreement
Form 8-K, items 1.01, 2.03, 8.01. Also took on a new financial obligation; reported other events.
- 8-K
Future Vision II Acquisition Corp. entered a material agreement
Form 8-K, items 1.01, 2.03, 3.02, 8.01. Also took on a new financial obligation; sold shares without registration; reported other events.
- 8-K
Healthstream Inc entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
Addentax Group Corp. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
AIM ImmunoTech Inc. entered a material agreement
Form 8-K, items 1.01, 3.02. Also sold shares without registration.
- 8-K
Cardiff Oncology, Inc. entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
Clean Energy Technologies, Inc. entered a material agreement
Form 8-K, items 1.01, 2.03, 3.02. Also took on a new financial obligation; sold shares without registration.
- 8-K
Magnolia Oil & Gas Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
Biovie Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
BKV Corp entered a material agreement
Form 8-K, item 1.01.
- 8-K
Genasys Inc. entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
KKR Private Equity Conglomerate LLC entered a material agreement
Form 8-K, items 1.01, 2.03. Also took on a new financial obligation.
- 8-K
AirJoule Technologies Corp. entered a material agreement
Form 8-K, items 1.01, 3.02, 7.01. Also sold shares without registration; made a Regulation FD disclosure.
- 8-K
DevvStream Corp. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Drugs Made In America Acquisition Corp. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Baldwin Insurance Group, Inc. entered a material agreement
Form 8-K, item 1.01.
- 8-K
Change Agents Corporation. entered a material agreement
Form 8-K, item 1.01.
- 8-K
CitroTech Inc. entered a material agreement
Form 8-K, items 1.01, 7.01. Also made a Regulation FD disclosure.
- 8-K
NPK International Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Rimini Street, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
State Street Corp reports a director or officer change
Form 8-K, item 5.02.
- 8-K
lululemon athletica inc. reports a director or officer change
Form 8-K, items 5.02, 5.03. Also amended its articles or bylaws.
- 8-K
Rare Element Resources Ltd reports a director or officer change
Form 8-K, item 5.02.
- 8-K
National Healthcare Properties, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
TransparentBusiness, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Vista Credit Strategic Lending Corp. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Firefly Neuroscience, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Graco Inc reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Lesaka Technologies Inc reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Inseego Corp. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Azio AI Holdings, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Apogee Enterprises, Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Crown Castle Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Chatham Lodging Trust reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Flowserve Corp reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Health Catalyst, Inc. reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
I-ON Digital Corp. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Ingles Markets Inc reports a director or officer change
Form 8-K, items 5.02, 5.03, 8.01. Also amended its articles or bylaws; reported other events.
- 8-K
Inmune Bio, Inc. reports a director or officer change
Form 8-K, items 5.02, 8.01. Also reported other events.
- 8-K
A10 Networks, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Bimini Capital Management, Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Biomarin Pharmaceutical Inc reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Chipotle Mexican Grill Inc reports a director or officer change
Form 8-K, item 5.02.
- 8-K
CIMG Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Bowhead Specialty Holdings Inc. reports a director or officer change
Form 8-K, item 5.02.
- 8-K
Dexcom Inc reports a director or officer change
Form 8-K, items 5.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Eos Energy Enterprises, Inc. took on a new financial obligation
Form 8-K, items 2.03, 7.01. Also made a Regulation FD disclosure.
- Offering
Syra Health Corp filed to register new shares
Form S-1, registration statement.
- Offering
MFB Bancorp, Inc. filed to register new shares
Form S-1, registration statement.
- 8-K
Stewards, Inc. changed shareholders’ rights
Form 8-K, items 3.03, 5.03, 5.07. Also reported shareholder vote results; amended its articles or bylaws.
- 8-K
Tilray Brands, Inc. sold shares without registration
Form 8-K, item 3.02.
- 8-K
Nextnrg, Inc. changed shareholders’ rights
Form 8-K, items 3.03, 5.03, 8.01. Also amended its articles or bylaws; reported other events.
- 8-K
First Citizens Bancshares Inc /DE/ changed shareholders’ rights
Form 8-K, item 3.03.
- Offering
Laser Photonics Corp published a final prospectus
Form 424B4, prospectus for a priced offering.
- 8-K
R F Industries Ltd published results
Form 8-K, item 2.02.
- 8-K
NewtekOne, Inc. published results
Form 8-K, item 2.02.
- 8-K
Radiant Logistics, Inc published results
Form 8-K, item 2.02.
- 8-K
Pharma-Bio Serv, Inc. published results
Form 8-K, item 2.02.
- 8-K
Benitec Biopharma Inc. published results
Form 8-K, item 2.02.
- 8-K
CubeSmart published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Dave & Buster's Entertainment, Inc. published results
Form 8-K, item 2.02.
- 8-K
CubeSmart, L.P. published results
Form 8-K, items 2.02, 7.01. Also made a Regulation FD disclosure.
- 8-K
Immersion Corp published results
Form 8-K, items 2.02, 8.01. Also reported other events.
- 8-K
Kestra Medical Technologies, Ltd. published results
Form 8-K, item 2.02.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Frost Phillip MD ET AL and Safe Pro Group Inc.
- 8-K
Polaryx Therapeutics, Inc. reported shareholder vote results
Form 8-K, item 5.07.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Duquesne Family Office LLC and Guardian Metal Resources PLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Capricor Therapeutics, Inc. and Millennium Management LLC.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Doerr L John and SunPower Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Crosslink Capital Inc and SunPower Inc.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Blue Laser Fusion, Inc. and SPARX Asset Management Co., Ltd.
- 8-K
Payoneer Global Inc. reported shareholder vote results
Form 8-K, item 5.07.
- Stake 13G
New passive stake of 5% or more
Schedule 13G naming Andretti Acquisition Corp. II and Linden Capital L.P.
- 8-K
Dorian LPG Ltd. reported shareholder vote results
Form 8-K, item 5.07.
- 8-K
Eplus Inc reported shareholder vote results
Form 8-K, items 5.03, 5.07. Also amended its articles or bylaws.
- 8-K
Hudson Acquisition I Corp. reported shareholder vote results
Form 8-K, items 5.07, 8.01. Also reported other events.
- 8-K
BlackSky Technology Inc. reported shareholder vote results
Form 8-K, item 5.07.
- 8-K
Viking Global Technologies, Inc. amended its articles or bylaws
Form 8-K, item 5.03.
- 8-K
Zion Oil & Gas Inc amended its articles or bylaws
Form 8-K, item 5.03.
- 8-K
Lument Finance Trust, Inc. amended its articles or bylaws
Form 8-K, items 5.03, 7.01. Also made a Regulation FD disclosure.
- Offering
Electra Therapeutics, Inc. amended its share registration
Form S-1/A, amended registration statement.
- Offering
Little West Holdings Inc. amended its share registration
Form S-1/A, amended registration statement.
- Offering
Bamboo Insurance Services, Inc. amended its share registration
Form S-1/A, amended registration statement.
- Offering
Veri MedTech Holdings, Inc. amended its share registration
Form S-1/A, amended registration statement.
- Offering
Polar Power, Inc. amended its share registration
Form S-1/A, amended registration statement.
- Offering
ADARx Pharmaceuticals, Inc. amended its share registration
Form S-1/A, amended registration statement.
- Offering
Eaglesky Acquisition Corp amended its share registration
Form S-1/A, amended registration statement.
- Offering
Leader's Advantage Acquisition Corp. amended its share registration
Form S-1/A, amended registration statement.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Grab Holdings Ltd and Toyota Motor Corp/.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Alta Partners LLC and Envoy Medical, Inc.
- 8-K
Power REIT set a date for shareholder director nominations
Form 8-K, item 5.08.
- Stake 13G
Updated passive stake of 5% or more
Schedule 13G/A naming Duquesne Family Office LLC and Guardian Metal Resources PLC.
- 8-K
Elicio Therapeutics, Inc. set a date for shareholder director nominations
Form 8-K, items 5.08, 8.01. Also reported other events.
- Proxy
Western Asset Mortgage Opportunity Fund Inc. filed its proxy statement for a shareholder meeting
Schedule 14A.
- Proxy
Western Asset Global High Income Fund Inc. filed its proxy statement for a shareholder meeting
Schedule 14A.
- Proxy
Western Asset Emerging Markets Debt Fund Inc. filed its proxy statement for a shareholder meeting
Schedule 14A.
- Insider trades
595 insider-trade forms filed by directors and major holders
Shown as a count until Loro reads the transactions inside them: who bought or sold, how many shares, at what price. Most filings: UL Solutions Inc. (20), Huntington Ingalls Industries, Inc. (18), CDW Corp (16), Essent Group Ltd. (14), Solstice Advanced Materials Inc. (12), Prudential Financial Inc (11).
SEC Form 4
Showing the 150 most material of 283.